Ballinger Kevin J. 4
4 · BOSTON SCIENTIFIC CORP · Filed Mar 5, 2020
Insider Transaction Report
Form 4
Ballinger Kevin J.
SVP & Pres, Interven Cardio
Transactions
- Exercise/Conversion
Common Stock
2020-03-03+3,303→ 83,388 total - Tax Payment
Common Stock
2020-03-03$37.23/sh−1,507$56,106→ 81,881 total - Sale
Common Stock
2020-03-04$38.05/sh−1,796$68,338→ 80,085 total - Exercise/Conversion
Deferred Stock Units
2020-03-03−3,303→ 6,606 totalExp: 2022-03-03→ Common Stock (3,303 underlying)
Footnotes (4)
- [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- [F3]This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- [F4]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant.